Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine

被引:25
|
作者
Nystrom, Jessica [1 ]
Cardell, Kristina [2 ]
Bjornsdottir, Thora Bjorg [1 ]
Fryden, Aril [2 ]
Hultgren, Catharina [1 ]
Sallberg, Matti [1 ]
机构
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Virol, S-14186 Huddinge, Sweden
[2] Linkoping Univ Hosp, Dept Infect Dis, S-58183 Linkoping, Sweden
关键词
Hepatitis B virus; HBV; HBsAg; Vaccine; Non-responder;
D O I
10.1016/j.vaccine.2008.08.054
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We Successfully re-vaccinated hepatitis B Virus (HBV) vaccine non-responders Using a double dose of the combined hepatitis A virus (HAV) and HBV vaccine. The hope was to improve priming of hepatitis B surface antigen (HBsAg)-specific cell mediated immune response (CMI) by an increased antigen dose and a theoretical adjuvant-effect from the local presence of a HAV-specific CMI. A few non-responders had a detectable HBsAg-specific CMI before re-vaccination. An in vitro detectable HBsAg-specific CMI was primed equally effective in non-responders (58%) as in first time vaccine recipients (68%). After the third dose a weak, albeit significant, association was observed between the magnitude of HBsAg-specific proliferation and anti-HBs levels. This regimen improves the priming of HBsAg-specific CMIs and antibodies. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5967 / 5972
页数:6
相关论文
共 50 条
  • [21] Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen
    Cooreman, MP
    Leroux-Roels, G
    Paulij, WP
    JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (03) : 237 - 247
  • [22] Immune response to second vaccination series of hepatitis B virus among booster dose non-responders
    Salama, Iman I.
    Sami, Samia M.
    Salama, Somaia I.
    Rabah, Thanaa Mahmoud
    El Etreby, Lobna Ahmed
    Hamid, Amany T. Abdel
    Elmosalami, Dalia
    El Hariri, Hazem
    Said, Zeinab N.
    VACCINE, 2016, 34 (16) : 1904 - 1908
  • [23] Hepatitis B virus infection seromarkers among college freshmen and their immune responses to different vaccination policies of hepatitis B vaccine
    Xu, Yuyang
    Liu, Yan
    Wang, Jun
    Che, Xinren
    Zhang, Xuechao
    Jiang, Wei
    Du, Jian
    Zhang, Xiaoping
    Gu, Wenwen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4587 - 4594
  • [24] The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine
    Brodersen, HP
    Beckers, B
    Kohler, H
    Dahlmanns, C
    Kruska, L
    Larbig, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (12) : 2756 - 2757
  • [25] Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis
    Verkade, M. A.
    van Druningen, C. J.
    de Hoek, C. T. op
    Weimar, W.
    Betjes, M. G. H.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2007, 7 (02) : 65 - 71
  • [26] Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis
    M. A. Verkade
    C. J. van Druningen
    C. T. op de Hoek
    W. Weimar
    M. G. H. Betjes
    Clinical and Experimental Medicine, 2007, 7 : 65 - 71
  • [27] Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers
    Reutter, J
    Bart, PA
    Francioli, P
    Safary, A
    Frei, PC
    JOURNAL OF VIRAL HEPATITIS, 1998, 5 (03) : 205 - 211
  • [28] The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen
    Xing, Yiping
    Huang, Zuhu
    Lin, Yan
    Li, Jun
    Chou, Te-Hui
    Lu, Shan
    Wang, Shixia
    VACCINE, 2008, 26 (40) : 5145 - 5152
  • [29] Immune responses elicited in hepatitis B virus transgenic mice by B7-H1 and HBsAg vaccine
    Su, W. J.
    Bai, X. F.
    Liu, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S74 - S74
  • [30] A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine
    Zhang, Chongwen
    Gong, Li
    Chen, Yuanyuan
    Wang, Xiaohua
    Zhu, Sibo
    Li, Ding
    Pang, Yun
    Yin, Yue
    Liu, Xi
    Zhu, Naishuo
    MOLECULAR IMMUNOLOGY, 2013, 53 (1-2) : 60 - 71